Yıl: 2018 Cilt: 34 Sayı: 2 Sayfa Aralığı: 87 - 91 Metin Dili: İngilizce DOI: 10.5222/otd.2018.25901 İndeks Tarihi: 29-07-2019

Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience

Öz:
Objective: Autosomal Dominant Polycystic Kidney Disease(ADPKD) is the most common hereditary kidney diseaseand nephrolithiasis is frequent among ADPKD patientscompared with general population. In this study, we aimedto review the factors associated with the development ofkidney stones in ADPKD patients.Material and Methods: A total of 118 ADPKD patientswere retrospectively evaluated. Demographic characteristics,serum biochemistry, and clinical features were comparedin stone formers and non-stone formers.Results: Twenty-eight patients (23.7%) were diagnosedwith kidney stones. History of frequent urinary tract infections(UTIs), the presence of liver cyst and gross hematuriawere found to be associated with the presence of kidneystones.Conclusion: According to our findings nephrolithiasisshould be kept in mind in ADPKD patients with liver cyst,hematuria, and recurrent UTIs.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Otozomal Dominant Polikistik Böbrek Hastalarında Nefrolitiazis Risk Faktörlerinin Değerlendirmesi: Tek Merkez Deneyimi

Öz:
Amaç: Otozomal Dominant Polikistik Böbrek (ODPKB) Hastalığı, en sık görülen kalıtsal böbrek hastalığıdır ve nefrolitiyaz genel popülasyonla karşılaştırıldığında bu hastalarda daha sıktır. Çalışmamızda, ODPKB hastalarında böbrek taşı gelişimi ile ilişkili faktörleri gözden geçirmeyi amaçladık. Gereç ve Yöntem: Toplam 118 ODPKB hastası geriye dönük olarak değerlendirildi. Taş oluşturanlar ve taş oluşturmayanlar arasında demografik özellikler, serum biyokimyası ve klinik özellikler karşılaştırıldı. Bulgular: Yirmi sekiz hastada (%23,7) böbrek taşı tespit edildi. Tekrarlayan idrar yolu enfeksiyonu (İYE) öyküsü, karaciğer kisti varlığı ve gros hematüri böbrek taş varlığı ile ilişkili bulunmuştur. Sonuç: Bulgularımıza göre karaciğer kisti, hematüri ve tekrarlayan İYE’li ODPKB hastalarında nefrolitiyaz olabileceği akılda tutulmalıdır.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. Am J Kidney Dis 2014;64(4):592-9. https://doi.org/10.1053/j.ajkd.2014.05.020
  • 2. Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: Core curriculum 2016. Am J Kidney Dis 2016;67(5):792-810. https://doi.org/10.1053/j.ajkd.2015.07.037
  • 3. Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 1988;11(4):318-25. https://doi.org/10.1016/S0272-6386(88)80137-9
  • 4. Levine E, Grantham JJ. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol 1992;159(1):77-81. https://doi.org/10.2214/ajr.159.1.1609726
  • 5. Ferraz RR, Fonseca JM, Germino GG, Onuchic LF, Heilberg IP. Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease. Urolithiasis 2014;42(4):301-7. https://doi.org/10.1007/s00240-014-0664-1
  • 6. Amar AD, Das S, Egan RM. Management of urinary calculous disease in patients with renal cysts: review of 12 years of experience in 18 patients. J Urol 1981;125(2):153-6. https://doi.org/10.1016/S0022-5347(17)54943-5
  • 7. Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Johnson AM, et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000;36(1):53-7. https://doi.org/10.1053/ajkd.2000.8266
  • 8. Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2009;4(4):838-44. https://doi.org/10.2215/CJN.03100608
  • 9. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2009;20(1):205- 12. https://doi.org/10.1681/ASN.2008050507 10. Mufti UB, Nalagatla SK. Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol 2010;24(10):1557-61. https://doi.org/10.1089/end.2010.0093
  • 11. Alsaedi AJ, Jamal H, Al-Windawi S. The prevalence of hypertension and nephrolithiasis in a sample of Iraqi patients with autosomal-dominant polycystic kidney disease. Saudi J Kidney Dis Transpl 2011;22(5):1044-5.
  • 12. Bajrami V, Idrizi A, Roshi E, Barbullushi M. Association between Nephrolithiasis, Hypertension and Obesity in Polycystic Kidney Disease. Open Access Maced J Med Sci 2016;4(1):43-6. https://doi.org/10.3889/oamjms.2016.010
  • 13. Bajwa ZH, Sial KA, Malik AB, Steinman TI. Pain patterns in patients with polycystic kidney disease. Kidney Int 2004;66(4):1561-9. https://doi.org/10.1111/j.1523-1755.2004.00921.x
  • 14. Dimitrakov D, Simeonov S. Studies on nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Folia Med (Plovdiv) 1994;36(3):27-30. 15. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329(5):332-42. https://doi.org/10.1056/NEJM199307293290508
  • 16. Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992;20(2):140-3.
  • https://doi.org/10.1016/S0272-6386(12)80541-5 17. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 2003;64(6):2204-13. https://doi.org/10.1046/j.1523-1755.2003.00317.x
  • 18. Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993;22(4):513-9. https://doi.org/10.1016/S0272-6386(12)80922-X
  • 19. Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2012;7(3):479-86. https://doi.org/10.2215/CJN.09500911
  • 20. Shoag J, Tasian GE, Goldfarb DS, Eisner BH. The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis 2015;22(4):273-8. https://doi.org/10.1053/j.ackd.2015.04.004
APA Kaygısız O, COŞKUN B, Oruc A, GEDİK C, ERSOY A, Kordan Y, Kılıçarslan H, YILDIZ A (2018). Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. , 87 - 91. 10.5222/otd.2018.25901
Chicago Kaygısız Onur,COŞKUN BURHAN,Oruc Aysegul,GEDİK Cemil Cihad,ERSOY ALPARSLAN,Kordan Yakup,Kılıçarslan Hakan,YILDIZ ABDULMECİT Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. (2018): 87 - 91. 10.5222/otd.2018.25901
MLA Kaygısız Onur,COŞKUN BURHAN,Oruc Aysegul,GEDİK Cemil Cihad,ERSOY ALPARSLAN,Kordan Yakup,Kılıçarslan Hakan,YILDIZ ABDULMECİT Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. , 2018, ss.87 - 91. 10.5222/otd.2018.25901
AMA Kaygısız O,COŞKUN B,Oruc A,GEDİK C,ERSOY A,Kordan Y,Kılıçarslan H,YILDIZ A Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. . 2018; 87 - 91. 10.5222/otd.2018.25901
Vancouver Kaygısız O,COŞKUN B,Oruc A,GEDİK C,ERSOY A,Kordan Y,Kılıçarslan H,YILDIZ A Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. . 2018; 87 - 91. 10.5222/otd.2018.25901
IEEE Kaygısız O,COŞKUN B,Oruc A,GEDİK C,ERSOY A,Kordan Y,Kılıçarslan H,YILDIZ A "Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience." , ss.87 - 91, 2018. 10.5222/otd.2018.25901
ISNAD Kaygısız, Onur vd. "Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience". (2018), 87-91. https://doi.org/10.5222/otd.2018.25901
APA Kaygısız O, COŞKUN B, Oruc A, GEDİK C, ERSOY A, Kordan Y, Kılıçarslan H, YILDIZ A (2018). Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. Okmeydanı Tıp Dergisi, 34(2), 87 - 91. 10.5222/otd.2018.25901
Chicago Kaygısız Onur,COŞKUN BURHAN,Oruc Aysegul,GEDİK Cemil Cihad,ERSOY ALPARSLAN,Kordan Yakup,Kılıçarslan Hakan,YILDIZ ABDULMECİT Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. Okmeydanı Tıp Dergisi 34, no.2 (2018): 87 - 91. 10.5222/otd.2018.25901
MLA Kaygısız Onur,COŞKUN BURHAN,Oruc Aysegul,GEDİK Cemil Cihad,ERSOY ALPARSLAN,Kordan Yakup,Kılıçarslan Hakan,YILDIZ ABDULMECİT Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. Okmeydanı Tıp Dergisi, vol.34, no.2, 2018, ss.87 - 91. 10.5222/otd.2018.25901
AMA Kaygısız O,COŞKUN B,Oruc A,GEDİK C,ERSOY A,Kordan Y,Kılıçarslan H,YILDIZ A Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. Okmeydanı Tıp Dergisi. 2018; 34(2): 87 - 91. 10.5222/otd.2018.25901
Vancouver Kaygısız O,COŞKUN B,Oruc A,GEDİK C,ERSOY A,Kordan Y,Kılıçarslan H,YILDIZ A Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience. Okmeydanı Tıp Dergisi. 2018; 34(2): 87 - 91. 10.5222/otd.2018.25901
IEEE Kaygısız O,COŞKUN B,Oruc A,GEDİK C,ERSOY A,Kordan Y,Kılıçarslan H,YILDIZ A "Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience." Okmeydanı Tıp Dergisi, 34, ss.87 - 91, 2018. 10.5222/otd.2018.25901
ISNAD Kaygısız, Onur vd. "Evaluation of Nephrolithiasis Risk Factors in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single Center Experience". Okmeydanı Tıp Dergisi 34/2 (2018), 87-91. https://doi.org/10.5222/otd.2018.25901